OBJECTIVE: Smokers with mental illness and addictive disorders account for nearly one in two cigarettes sold in the United States and are at high risk for smoking-related deaths and disability. Psychiatry residency programs provide a unique arena for disseminating tobacco treatment guidelines, influencing professional norms, and increasing access to tobacco cessation services among smokers with mental illness. The current study evaluated the Rx for Change in Psychiatry curriculum, developed for psychiatry residency programs and focused on identifying and treating tobacco dependence among individuals with mental illness. METHODS: The 4-hour curriculum emphasized evidence-based, patient-oriented cessation treatments relevant for all tobacco users, including those not yet ready to quit. The curriculum was informed by comprehensive literature review, consultation with an expert advisory group, faculty interviews, and a focus group with psychiatry residents. This study reports on evaluation of the curriculum in 2005-2006, using a quasi-experimental design, with 55 residents in three psychiatry residency training programs in Northern California. RESULTS: The curriculum was associated with improvements in psychiatry residents' knowledge, attitudes, confidence, and counseling behaviors for treating tobacco use among their patients, with initial changes from pre- to posttraining sustained at 3-months' follow-up. Residents' self-reported changes in treating patients' tobacco use were substantiated through systematic chart review. CONCLUSION: The evidence-based Rx for Change in Psychiatry curriculum is offered as a model tobacco treatment curriculum that can be implemented in psychiatry residency training programs and disseminated widely, thereby effectively reaching a vulnerable and costly population of smokers.
OBJECTIVE: Smokers with mental illness and addictive disorders account for nearly one in two cigarettes sold in the United States and are at high risk for smoking-related deaths and disability. Psychiatry residency programs provide a unique arena for disseminating tobacco treatment guidelines, influencing professional norms, and increasing access to tobacco cessation services among smokers with mental illness. The current study evaluated the Rx for Change in Psychiatry curriculum, developed for psychiatry residency programs and focused on identifying and treating tobacco dependence among individuals with mental illness. METHODS: The 4-hour curriculum emphasized evidence-based, patient-oriented cessation treatments relevant for all tobacco users, including those not yet ready to quit. The curriculum was informed by comprehensive literature review, consultation with an expert advisory group, faculty interviews, and a focus group with psychiatry residents. This study reports on evaluation of the curriculum in 2005-2006, using a quasi-experimental design, with 55 residents in three psychiatry residency training programs in Northern California. RESULTS: The curriculum was associated with improvements in psychiatry residents' knowledge, attitudes, confidence, and counseling behaviors for treating tobacco use among their patients, with initial changes from pre- to posttraining sustained at 3-months' follow-up. Residents' self-reported changes in treating patients' tobacco use were substantiated through systematic chart review. CONCLUSION: The evidence-based Rx for Change in Psychiatry curriculum is offered as a model tobacco treatment curriculum that can be implemented in psychiatry residency training programs and disseminated widely, thereby effectively reaching a vulnerable and costly population of smokers.
Authors: Kareen Suchanek Hudmon; Robin L Corelli; Eunice Chung; Berit Gundersen; Lisa A Kroon; Leann M Sakamoto; Kymberli K Hemberger; Christine Fenlon; Alexander V Prokhorov Journal: J Cancer Educ Date: 2003 Impact factor: 2.037
Authors: Paul Rohde; Peter M Lewinsohn; Richard A Brown; Jeffrey M Gau; Christopher W Kahler Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Maria A Oquendo; Hanga Galfalvy; Stefani Russo; Steven P Ellis; Michael F Grunebaum; Ainsley Burke; J John Mann Journal: Am J Psychiatry Date: 2004-08 Impact factor: 18.112
Authors: Andrew N Schmelz; Brandon Nixon; Anna McDaniel; Karen Suchanek Hudmon; Alan J Zillich Journal: Am J Pharm Educ Date: 2010-03-10 Impact factor: 2.047
Authors: Sandra A Mitchell; Cheryl A Fisher; Clare E Hastings; Leanne B Silverman; Gwenyth R Wallen Journal: Nurs Outlook Date: 2010 Nov-Dec Impact factor: 3.250
Authors: Li-Shiun Chen; Timothy B Baker; Jeanette M Korpecki; Kelly E Johnson; Jaime P Hook; Ross C Brownson; Laura J Bierut Journal: Psychiatr Serv Date: 2018-06-01 Impact factor: 3.084